||
https://mp.weixin.qq.com/s/9Ts446Q_-5HH7WzbMbx7dw
(4)
(2)
(2)
https://fx.wanfangdata.com.cn/keytrends/detail?theme_name=Cimavax
http://www.pubmedplus.cn/P/SearchQuickResult?wd=44914d00-6293-40c5-b117-9ac5ed5ff54b
01. | Humans | 24 篇 | 70.588% |
02. | Cancer Vaccines | 20 篇 | 58.824% |
03. | Lung Neoplasms | 19 篇 | 55.882% |
04. | Carcinoma, Non-Small-Cell Lung | 18 篇 | 52.941% |
05. | Epidermal Growth Factor | 10 篇 | 29.412% |
06. | Female | 9 篇 | 26.471% |
07. | Immunotherapy, Active | 8 篇 | 23.529% |
08. | Antibodies, Monoclonal | 7 篇 | 20.588% |
09. | Male | 7 篇 | 20.588% |
10. | Cuba | 6 篇 | 17.647% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-8-20 11:14
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社